Munich, May 10, 2021
The working groups Beckmann, Carell, Hopfner, Hornung, Merkel, Schneider and Wagner belong to the CNATM.
The federal government plans to provide up to 450 million euros for the future clusters over the next ten years. If you add the expected mobilized private money, more than one billion euros can be activated for the regional innovation networks in Germany.
CNATM, the only finalist from Bavaria, aims to develop new nucleic acid-based therapies and vaccines for the treatment of diseases that were previously difficult to treat.
The management team of the cluster now has to submit a formal funding application for the conception phase to the BMBF by May 31, 2021.